Replimune Group Inc sell BMO Capital Markets
Start price
13.04.26
/
50%
€1.51
Target price
13.04.27
€0.86
Performance (%)
596.88%
Price
04.08.26
€10.95
Summary
This prediction is currently active. The price for Replimune Group Inc has massively increased, which is bad news for the SELL prediction by BMO_Capital_Markets. This prediction currently runs until 13.04.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | 121.272% | 121.272% |
| iShares Core DAX® | 3.258% | 2.069% |
| iShares Nasdaq 100 | 5.697% | -0.604% |
| iShares Nikkei 225® | 7.770% | -4.746% |
| iShares S&P 500 | 2.795% | 2.251% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group (REPL) was downgraded by BMO Capital Markets from "market perform" to "underperform". They now have a $1.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€10.65
30.06.26
30.06.26
€14.04
30.06.27
30.06.27
-1.31%
04.08.26
04.08.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€2.40
23.07.25
23.07.25
€1.70
23.07.26
23.07.26
275.67%
24.07.26
24.07.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-48.84%
23.01.26
23.01.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-49.03%
23.11.25
23.11.25